WPRIM Management System> DCMS> Chinese Journal of Clinical Pharmacology and Therapeutics> 2020> 25> 4

Volume: 25 Issue: 4

1. Protection of subjects' legal rights, welfare and safety in clinical trials of COVID-19 Page:421—425
2. Evaluation of the effects of resveratrol on the activity human cytochrome P450 through combined probe method Page:426—432
3. Apatinib combined with capecitabine in the treatment of advanced triple-negative breast cancer as third-line therapy: An observational study Page:433—439
4. Effects of SSRI antidepressant sertraline on ocular surface function in patients with postpartum depression Page:440—446
5. Temperature selection of intravesical sodium hyaluronate in the treatment of interstitial cystitis Page:447—454
6. Effects of atorvastatin and folic acid tablets on homocysteine and carotid atherosclerosis in patients with type H hypertension Page:455—459
7. Effects of pharmaceutical excipients on CYP3A activity and its guiding effects on quality and efficacy consistency evaluation of generic drugs Page:460—466
8. Pharmacological targets and clinical application of traditional Chinese medicine and active components in the prevention and treatment for depression Page:467—474
9. Progress in drug therapy for advanced triple-negative breast cancer Page:475—480
10. Expression of long non-coding RNA LINC00844 in hepatocellular carcinoma and its inhibiting effect on cell proliferation and migration Page:366—372
11. Research of peripheral mechanism of opioid receptor on testosterone secretion Page:373—379
12. Inhibiting RNA methylase NSUN2 reduce the invasion and migration of gastric cancer cell Page:380—386
13. Forsythiaside B inhibits the proliferation activity of HeLa cells though transcription factor NF-κB Page:387—392
14. Preparation of genistein combined polysaccharide liposomes and its inhibitory effects on prostate cancer Page:393—400
15. Mulberry polysaccharides improves the chemotherapy of liver cancer ascites tumor-bearing mice by regulating the PI3K/AKT/mTOR pathway Page:401—407
16. Application of model-informed drug development approach in dose optimization: Insights from the modification of nivolumab dosage regimen Page:408—412
17. Response surface model to optimize the concentration range of propofol and remifentanil Page:413—420

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.